Key result
Core lab echo measurements predict subsequent clinical endpoints, unlike local investigator assessments.
Why the study?
This study aimed to examine differences in measurements of left ventricular dimensions and function and their prognostic value between local investigators and a core laboratory in a multicentre serial echocardiographic study.
Cohort (n=756)
Yes
Core laboratory echocardiographic analysis may enhance prognostication over local assessments; leaves open whether standardized core lab review should be adopted clinically.
AIMS: To examine differences in measurements of left ventricular dimensions and function, and prognostic value between local investigators and a core laboratory in a multicentre serial echocardiographic study. METHODS AND RESULTS: Seven hundred and fifty-six patients with acute myocardial infarction and preserved left ventricular function were examined at baseline and after 3 months with measurements by the biplane Simpson's method, and followed prospectively from 3 to 24 months. At baseline and 3 months local investigators relative to the core laboratory measured lesser end-diastolic volume by 8 and 6 ml (P<0.001), end-systolic volume by 3 and 2 ml (P<0.01), and ejection fraction by 0.0 and 0.6% (P<0.01), respectively. Local investigators and the core laboratory measured an increase in left ventricular end-diastolic volume of 8.6 and 6.9 ml, and in left ventricular end-systolic volume of 5.2 and 4.3 ml, and a decrease in left ventricular ejection fraction of 0.6 and 0.0%. Using the Cox proportionate hazards model, the prognostic value for subsequent clinical endpoints was significant both for the 3-month values (P<0.05) and changes (P<0.005) measured by the core laboratory, but not by local investigators. CONCLUSION: Only measurements in the core laboratory had significant prognostic value for subsequent clinical endpoints. These results strongly support the use of a core laboratory in studies employing echocardiographic measurements.
No takes yet. Share an insight, caveat, or question.
Hole et al. (2002) conducted a cohort in Acute myocardial infarction (n=756). Core laboratory echocardiographic measurements vs. Local investigator echocardiographic measurements was evaluated on Subsequent clinical endpoints and differences in left ventricular dimensions and function (p=<0.005). Core laboratory echocardiographic measurements, unlike local investigator assessments, had significant prognostic value for subsequent clinical endpoints at 3 months (P<0.05) and for changes (P<0.005).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: